Details for New Drug Application (NDA): 213598
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Summary for 213598
Tradename: | CELECOXIB |
Applicant: | Nanjing |
Ingredient: | celecoxib |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 213598
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | May 13, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription